Gregory Scott Duncan
CIK: 0001831127
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 5, 2026DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
330K shares- - Jan 26, 2026CRMD
CorMedix Inc.
Award(A)Direct30.5K shares- - Dec 4, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
460K shares- - Sep 16, 2025CRMD
CorMedix Inc.
Exercise(M)Direct13.3K shares at avg. $8.32$111K - Jun 27, 2025DWTX
Dogwood Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
40K shares- - Jan 17, 2025CRMD
CorMedix Inc.
Award(A)Direct25K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 5, 2026 |  DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 330,000 | - | - | Direct |
| Jan 26, 2026 |  CRMD CorMedix Inc. | Award(A) | 30,453 | - | $0 | Direct |
| Dec 4, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 460,000 | - | - | Direct |
| Sep 16, 2025 | CRMD CorMedix Inc. | Exercise(M) | 13,333 | $8.32 | $110,931 | Direct |
| Jun 27, 2025 | DWTX Dogwood Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 40,000 | - | - | Direct |
| Jan 17, 2025 | CRMD CorMedix Inc. | Award(A) | 25,000 | - | $0 | Direct |
1-6 of 6 transactions
About Duncan Gregory Scott
Duncan Gregory Scott (SEC CIK 0001831127) files insider reports with the SEC as CHIEF EXECUTIVE OFFICER of Dogwood Therapeutics, Inc. (DWTX) and Director of CorMedix Inc. (CRMD).
Signal8 holds 6 ownership filings by Duncan Gregory Scott, all Form 4s, filed between Jan 22, 2025 and Mar 6, 2026. Those filings report 6 transactions, from Jan 17, 2025 to Mar 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Duncan Gregory Scott's filings is in ALPHARETTA, GA.
Recent filings by Duncan Gregory Scott
- Mar 5, 2026: Grant or award of DWTX derivative securities (Form 4, code A).
- Jan 26, 2026: Grant or award of CRMD shares (Form 4, code A).
- Dec 4, 2025: Grant or award of DWTX derivative securities (Form 4, code A).
- Sep 16, 2025: Option exercise of CRMD shares (Form 4, code M).
- Jun 27, 2025: Grant or award of DWTX derivative securities (Form 4, code A).
Other insiders filing for Dogwood Therapeutics, Inc. (DWTX)
- Sealbond Ltd, Director
- De La Rosa Abel, Director
- Thomas John C, Director
- Whitley Richard James, Director
- Keefer David R, Director
- Grosswald Ralph, SVP OF OPERATIONS